{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:54:56Z","timestamp":1785354896263,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s65738","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T23:15:54Z","timestamp":1446074154000},"page":"5827","source":"Crossref","is-referenced-by-count":16,"title":["Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date"],"prefix":"10.2147","author":[{"given":"Ferdinando","family":"Squitieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"de Yebenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,10]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=27747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:58:40Z","timestamp":1477868320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/profile-of-pridopidine-and-its-potential-in-the-treatment-of-huntingto-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s65738","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}